Logo

American Heart Association

  12
  0


Final ID: MDP1030

Enhancing Care for Patients with ACS in Mexico: Impact of the Get With The Guidelines®-Coronary Artery Disease Mexico Project at the National Institute of Cardiology

Abstract Body (Do not enter title and authors here): Background: The GWTG initiative has improved global patient care. We introduced GWTG-CAD at Mexico’s largest referral center, the National Institute of Cardiology. This is an independent before/after quality analysis.
Hypothesis: Implementing a standardized tool will improve ACS patient management and guideline-recommended therapies.
Aims: To compare the center’s data before/after implementing the GWTG-CAD tool registry.
Methods: Retrospective, comparative study of ACS patients either transferred from eight referring hospitals or arriving directly to our center. We compared two groups: admissions from July 2022-March 2023 (before) and April 2023-April 2024 (after). Continuous variables are presented as mean±standard deviation or median and interquartile range, based on their distribution.
Data: A total of 473 patients, (202 in the before-period and 271 in the after-period). Age, gender, comorbidities and medical history were non-different between groups. The diagnoses included STEMI 73.2% vs. 58.1%, NSTEMI 23.3% vs. 38.8%, UA 3.4% vs. 2.9%. Symptom onset to first medical contact median time was 504(195-972 min) vs. 395(170-688 min), p=0.28. From the before-period, 32.2% underwent pPCI and 61.7% thrombolysis, vs. 46.2% and 42.9% in the after-period. Among all patients, the median time of arrival at referring hospital to PCI was 2,329(356-5142 min) during the before-period vs. 559(164-1702 min) in the after-period (p=0.002). Among STEMI transfers, the time of arrival at referring hospital to PCI was significantly lower (151[110-460] vs. 106[91-142] min, p=0.02). Among direct arrivals, door-to-balloon time was numerically, but not statistically lower (78.5[51-162] vs. 71[45-90] min, p=0.08). Prescription of guideline-recommended therapies from the before-period vs. after-period was DAPT (93.1% vs. 94.1%, p=0.68), ACEI/ARB (83.7% vs. 85.1%, p=0.68), BB (84.8% vs. 89.8%, p=0.10) and statins (97.3% vs. 95.3%, p=0.26). The overall survival rate was (95.5 vs. 97.4%).
Conclusions: In this comparative study we observed a significant reduction of transfer to PCI times in all ACS patients after the implementation of the GWTG-CAD project. High prescription of guideline-recommended therapies at discharge were documented.
  • Najera-rojas, Andrea  ( National Institute of Caridology , Mexico City , Mexico )
  • Arias-mendoza, Alexandra  ( National Institute of Caridology , Mexico City , Mexico )
  • Araiza, Diego  ( National Institute of Caridology , Mexico City , Mexico )
  • Robles-ledesma, Mariana  ( National Institute of Caridology , Mexico City , Mexico )
  • De Los Rios, Manuel  ( SINACOR , Culiacan , Sinaloa , Mexico )
  • Lugo Gavidia, Leslie Marisol  ( Consorcio Academico Mexicano para la obtencion de datos clinicos , Mexico City , Mexico )
  • Leiva, Jose Luis  ( Grupo Intervención San Luis , San Luis Potosi , San Luis Potosi , Mexico )
  • De Los Ríos Arce, Luis Fernando  ( National Institute of Caridology , Mexico City , Mexico )
  • Gopar-nieto, Rodrigo  ( National Institute of Caridology , Mexico City , Mexico )
  • Sierra Lara Martinez, Jorge Daniel  ( National Institute of Caridology , Mexico City , Mexico )
  • González Pacheco, Héctor  ( National Institute of Caridology , Mexico City , Mexico )
  • Author Disclosures:
    Andrea Najera-Rojas: DO NOT have relevant financial relationships | Alexandra Arias-Mendoza: No Answer | Diego Araiza: DO have relevant financial relationships ; Speaker:Boehringer Ingelheim:Active (exists now) ; Speaker:Viatris:Active (exists now) ; Speaker:Astra Zeneca:Active (exists now) ; Speaker:Novartis:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now) ; Speaker:Adium:Active (exists now) | Mariana Robles-Ledesma: No Answer | Manuel De Los Rios: DO NOT have relevant financial relationships | Leslie Marisol Lugo Gavidia: No Answer | Jose Luis Leiva: No Answer | Luis Fernando De los ríos Arce: No Answer | Rodrigo Gopar-Nieto: DO NOT have relevant financial relationships | Jorge Daniel Sierra Lara Martinez: No Answer | Héctor González Pacheco: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Driving Innovation: New Approaches to Optimizing Care and Outcomes

Sunday, 11/17/2024 , 03:15PM - 04:20PM

Moderated Digital Poster Session

More abstracts on this topic:
Impact of Time to Endovascular Securement on Outcomes in Aneurysmal Subarachnoid Hemorrhage

Chuck Carlin, Torabi Radmehr, Moldovan Krisztina, Furie Karen, Wolman Dylan, Jayaraman Mahesh, Mahta Ali, Wang Diana, Oldam Joseph, Taman Mazen, Duong Anna Duong, Voong Viva, Gupta Sahil, Haq Rakin, Feler Joshua

Area Deprivation Index Associated with Time to Presentation in Acute Ischemic Stroke and Eligibility for Standard Window versus Late Presenter Thrombolysis

Fritsche Colette, Corlin Laura, Leung Lester

More abstracts from these authors:
PORTAL VEIN PULSATILITY INDEX, INDEPENDENT OF INFERIOR VENA CAVA DILATATION, PREDICTS ACUTE KIDNEY INJURY IN PATIENTS WITH ACUTE HEART FAILURE

Gonzalez Macedo Eder, Arias-mendoza Alexandra, Araiza Diego, Latapi Ruiz Esparza Ximena, Hernandez-pastrana Sarai, Diaz Braiana, Garcia Villarejo Mariana, Neri Bale Raul Rodrigo, Santiago Hernández Alberto, Gopar-nieto Rodrigo, Sierra Lara Martinez Jorge Daniel

Systemic Inflammation Increases 30-Day Mortality of Patients with ST-Segment Elevation Myocardial Infarction

Cuellar Jorge, Torres Ramirez Perla Lizeth, Malchan Eduardo, Araiza Diego, Sierra Lara Martinez Jorge Daniel, Briseño Jose Luis, Gopar-nieto Rodrigo, Arias Alexandra, González Pacheco Héctor

You have to be authorized to contact abstract author. Please, Login
Not Available